9月16日-19日，2022年美国经导管心血管治疗学术会议（TCT 2022）将于波士顿拉开帷幕，并同步举办线上会议。为期4天的会议将展示来自世界各地的最新案例研究、新兴技术的实际应用，其中备受关注的最新临床科学研究（LBCS）专场，即将公布32项试验结果。

届时，严道医声网将持续跟踪报道，并邀请专家进行解读，部分日程早知道，更多最新信息邀您持续关注。

声明：严道医声网致力于传播权威、前沿的学术信息，及时将领域时事、前沿学术内容传递至国内，各项内容资料版权均归TCT 2022所有，如有涉及版权等问题，请第一时间与我们联系。

Session I 

北京时间: 9月17日 11:00PM-00:30AM（次日）

1. Cerebral Embolic Protection During Transcatheter Aortic Valve Replacement: The PROTECTED TAVR Study

1.经导管主动脉瓣置换术中的脑栓塞保护：PROTECTED TAVR研究

2. CLASP II D Trial: A Randomized Comparison of Transcatheter Edge-to-Edge Repair Devices for Degenerative Mitral Regurgitation – Clinical Outcomes and Echo Findings

2.CLASP II D试验：经导管缘对缘修复装置治疗退行性二尖瓣反流的随机比较——临床结局和超声发现

3. Transcatheter Edge-to-Edge Repair in Patients With Severe Mitral Regurgitation and Cardiogenic Shock: Insights From the TVT Registry

3.经导管缘对缘修复治疗严重二尖瓣反流合并心源性休克患者：TVT注册研究见解

4. Transcatheter Aortic Valve Replacement in Small Aortic Annuli: Results From the FRANCE-TAVI Registry

4.经导管主动脉瓣置换术治疗小主动脉瓣环：FRANCE-TAVI注册研究结果

Session II 

北京时间: 9月18日 02:00AM-03:30AM

5. Pathology of Self-Expanding Transcatheter Aortic Valve Failure and Hypo-Attenuated Leaflet Thickening (HALT)

5.自膨式经导管主动脉瓣置换术失败和低衰减瓣叶增厚（HALT）的病理学研究

6. 3-Year Outcomes from the Amplatzer™ Amulet™ Left Atrial Appendage Occluder Randomized Controlled Trial (Amulet IDE)

6.Amplatzer™ Amulet™ 左心耳封堵器随机对照试验的3年结果（Amulet IDE研究）

7. Three-Year Outcomes of the Randomized SCOPE I Trial Comparing the ACURATE Neo Versus the SAPIEN 3 Transcatheter Heart Valve System in Patients With Symptomatic Severe Aortic Stenosis

7.SCOPE I试验的3年结果：比较ACURATE Neo 与 SAPIEN 3经导管心脏瓣膜系统治疗症状性重度主动脉瓣狭窄患者

8. Contemporary Clinical and Echocardiographic Outcomes of 1000+ Patients Treated with MitraClip™ G4: Results from the EXPAND G4 Post Approval Study

8.1000多名接受MitraClip™G4治疗患者的当代临床和超声心动图结果：EXPAND G4获批后研究结果

9. The PASCAL IID Registry: A Prospective Registry for Transcatheter Edge-to-Edge Repair in Prohibitive Risk Patients With Degenerative Mitral Regurgitation and Complex Mitral Valve Anatomy

9.PASCAL IID注册研究：经导管缘对缘修复治疗有禁忌风险的退行性二尖瓣反流合并复杂二尖瓣解剖患者的前瞻性注册研究

10. Percutaneous or Surgical Management of Post-Infarction Ventricular Septal Defects: The United Kingdom National Registry

10.梗死后室间隔缺损的经皮或外科治疗：英国登记研究

Session III 

北京时间: 9月18日 11:00PM-00:30AM（次日）

11.Endovascular Ultrasound Renal Denervation to Treat Uncontrolled Hypertension: Primary Results of the Randomized, Sham-Controlled RADIANCE II Pivotal Trial

11.血管内超声去肾交感神经术治疗未控制的高血压（Uncontrolled Hypertension）：随机、假对照RADIANCE II关键试验的主要结果

12.Long-Term Outcomes Following Catheter-Based Renal Denervation in Patients With Uncontrolled Hypertension: 3-year Follow-up of the SYMPLICITY HTN-3 Trial  

12.未控制的高血压患者经导管去肾交感神经术治疗后的长期结果：SYMPLICITY HTN-3试验的3年随访

13. Pulmonary Artery Denervation for Pulmonary Arterial Hypertension: A Sham-Controlled Randomised Trial  

13. 肺动脉去神经术治疗肺动脉高压：一项随机、假对照试验

14. Outcomes for the Full US Cohort of he FLASH FlowTriever Mechanical Thrombectomy Registry in Pulmonary Embolism  

14. FLASH研究的全美国队列结果：FlowTriever机械血栓切除术治疗肺栓塞的注册研究

15. Ultrasound Guidance for Vascular Access for Cardiac Procedures: A Randomized Trial (UNIVERSAL)

15. 心脏手术血管通路的超声引导：一项随机试验（UNIVERSAL研究）

Session IV 

北京时间: 9月19日 02:00AM-03:30AM

16. CONFIDENCE Registry: Valve Hemodynamics and 1-Year Survival Following Implantation of the PorticoTM Valve in Experienced TAVI Centers

16.CONFIDENCE登记研究：在经验丰富的TAVI中心植入Portico™瓣膜后的瓣膜血流动力学和1年生存率

17. Mediators of Improvement in TAVR Outcomes Over Time: Insights from the STS-ACC TVT Registry

17.TAVR预后随时间改善的中介因素：来自STS-ACC TVT注册研究的见解

18. Frequency and Safety of Bioprosthetic Valve Fracture in Patients Undergoing Valve in Valve TAVR for Failed Surgical Valves Using the SAPIEN 3/Ultra Valves: Insights From Real-World Data  

18.使用 SAPIEN 3/Ultra 瓣膜对衰败的外科瓣膜进行 TAVR瓣中瓣手术的患者进行生物瓣膜扩裂技术的频率和安全性：真实世界数据

19. Increased Risk of Surgical Aortic Valve Replacement After Prior Transcatheter Versus Surgical Aortic Valve Replacement  

19.既往经导管 vs. 外科主动脉瓣置换术后的外科主动脉瓣置换术风险增加的比较

20. Cardiac Damage and Quality of Life After Aortic Valve Replacement: Results from the PARTNER Trials 

20.主动脉瓣置换术后的心脏损伤和生活质量：PARTNER试验的结果

21. Mid-term Echocardiographic Outcomes Following Transapical Mitral Valve Replacement: Updates from the Intrepid Pilot Study

21.经心尖二尖瓣置换术后的中期超声心动图结果：Intrepid Pilot研究的更新结果

Session V 

北京时间: 9月19日 11:00PM-00:30AM（次日）

22. Everolimus-Eluting Stents or Bypass Surgery for Mutivessel Coronary Artery Disease: 10-Year Outcomes of Multicenter Randomized Controlled BEST Trial

22.依维莫司洗脱支架或搭桥手术治疗多支冠状动脉疾病：多中心随机对照BEST试验的10年结果

23. Survival after PCI or CABG for Left Main Coronary Disease: A Report from the Swedish Coronary Angiography and Angioplasty Registry

23.左主干冠状动脉疾病PCI或CABG后的生存率：瑞典冠状动脉血管造影和血管成形术登记处的报告

24. A Randomised Controlled Trial Assessing The Value Of Computed Tomography Cardiac Angiography (CTCA) In Improving Patient Satisfaction And Reducing Contrast Load, Procedural Duration And Complications In Patients Who Had Previous Bypass Operation (CABG) Undergoing Invasive Coronary Angiography

24.一项评估计算机断层扫描冠状动脉造影（CTCA）在提高既往接受有创冠状动脉造影搭桥手术患者的满意度，减少造影剂负荷、手术时间和既往接受有创冠状动脉造影的搭桥手术（CABG）患者并发症方面价值的随机对照试验

25. FAME 3 Substudies: Clinical Outcomes Related to Anatomic vs. Functional Significance and Prognostic Value of Post-PCI FFR

25.FAME 3亚组研究：与PCI术后FFR参数的解剖/功能意义与预后价值相关的临床结果

26. Angiographic Quantitative Flow Ratio-Guided Coronary Intervention: Two-Year Outcomes of the FAVOR III China Trial

26.血管造影定量流量比引导的冠状动脉介入治疗：FAVOR III中国试验的两年结果

Session VI 

北京时间: 9月20日 02:00AM-03:30AM

27. Randomized, Double-Blind Trial of Routine Early Treatment with PCSK-9 inhibitor in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction

27.ST段抬高型心肌梗死患者经皮冠状动脉介入治疗后早期常规应用PCSK9抑制剂的随机双盲试验

28. Prevention of Radial Artery Occlusion With Rivaroxaban After Transradial Coronary Procedures: The RIVARAD Multicentric Randomized Trial

28.经桡动脉冠脉介入术后使用利伐沙班预防桡动脉闭塞：RIVARAD多中心随机试验

29. EXpansion of Stents After Intravascular lithoTripsy Versus Conventional Predilatation in CALCified Coronary Arteries

29.钙化冠状动脉血管内碎石术后支架扩张 vs. 常规预扩张的比较

30. Cutting Balloon to Optimize Predilatation for Stent Implantation: The COPS Randomized Trial

30.切割球囊优化支架植入前的预扩张：COPS随机试验

31. Impact of Underlying Causes of Acute Coronary Syndrome and 1-Year Outcomes After Percutaneous Coronary Intervention: Results From Optical Coherence Tomography Guided Primary Percutaneous Coronary Intervention Registry (TACTICS Registry)

31.急性冠状动脉综合征的潜在原因及直接经皮冠状动脉介入治疗后的1年结果：光学相干断层扫描引导的经皮冠状动脉介入治疗的结果（TACTICS 注册研究）

32. Two-Year Outcomes Of The Randomized Second-Generation Drug-Eluting Stents In Diabetes (SUGAR) Trial

32.SUGAR随机试验：糖尿病患者第二代药物洗脱支架植入后的2年结果